Concepedia
Statistics
Publications
11
Citations
350
H-Index
10
Active since
2010
Affiliations
Tel Aviv University(Current)
Stanford University
Technion – Israel Institute of Technology
Rappaport Family Institute for Research in the Medical Sciences
Dina Polyak is an author at Tel Aviv University specializing in drug delivery, pharmacy, and oncology.
Publications per year
2010–2021
Antiangiogenic Antitumor Activity of HPMA Copolymer–Paclitaxel–Alendronate Conjugate on Breast Cancer Bone Metastasis Mouse Model
Keren Miller, Anat Eldar‐Boock, Dina Polyak et al. · Molecular Pharmaceutics · 2011 · 99 citations
Medicine, Oncology, Pharmacology +16
Poly(ethylene glycol)–paclitaxel–alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases
Keren Miller, Chiara Clementi, Dina Polyak et al. · Biomaterials · 2013 · 86 citations
Pharmacy, Oncology, Pharmacology +17
Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases
Yingmei Li, Dina Polyak, Layton Lamsam et al. · npj Precision Oncology · 2021 · 29 citations · Full text
Life Sciences, Neurology, Oncology +17
Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors
Dina Polyak, Adva Krivitsky, Anna Scomparin et al. · Journal of Controlled Release · 2016 · 27 citations
Pharmacy, Molecular Pharmaceutics, Pharmaceutics +16
Development of PEGylated doxorubicin‐E‐[c(RGDfK)<sub>2</sub>] conjugate for integrin‐targeted cancer therapy
Dina Polyak, Claudia Ryppa, Anat Eldar‐Boock et al. · Polymers for Advanced Technologies · 2010 · 23 citations
Pharmacy, Pharmaceutics, Pharmacology +17
1–5 of 11